Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 287,259 | 214,985 | -10,783 | -60,400 | -88,278 |
| Depreciation Amortization | 11,454 | 46,688 | 51,296 | 47,654 | 47,923 |
| Income taxes - deferred | 911 | -290,516 | 0 | N/A | N/A |
| Accounts receivable | -47,674 | 47,595 | 45,088 | -96,687 | -7,453 |
| Accounts payable and accrued liabilities | -16,343 | -655 | 1,784 | -10,677 | 9,211 |
| Other Working Capital | -168,801 | 499,425 | 37,044 | -177,747 | 20,496 |
| Other Operating Activity | 278,821 | 85,384 | 49,720 | 185,752 | 39,226 |
| Operating Cash Flow | $345,627 | $602,906 | $174,149 | $-112,105 | $21,125 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,008 | -911,911 | -320,441 | 63,660 | -73,883 |
| PPE Investments | -30,905 | -13,608 | -34,764 | -7,107 | -7,692 |
| Purchase Of Investment | -10,000 | 0 | -2,500 | N/A | 0 |
| Sale Of Investment | N/A | N/A | 2,507 | 4,467 | 25,579 |
| Purchase Sale Intangibles | -5,377 | -4,044 | -3,093 | -4,421 | -4,056 |
| Other Investing Activity | -5,377 | -4,044 | -3,093 | -4,421 | -4,056 |
| Investing Cash Flow | $-41,274 | $-929,563 | $-358,291 | $56,599 | $-60,052 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 97,000 | 0 | 59,750 | 4,000 | 8,500 |
| Debt Repayment | -108,684 | 0 | -3,599 | -7,066 | -9,058 |
| Common Stock Issued | 175,767 | 475,865 | 255,106 | 13,417 | 24,888 |
| Common Stock Repurchased | -34,392 | 0 | N/A | N/A | N/A |
| Other Financing Activity | -29,670 | 0 | -82,170 | 1,043 | 396 |
| Financing Cash Flow | $100,021 | $475,865 | $229,087 | $11,394 | $24,726 |
| Exchange Rate Effect | 93 | -18 | N/A | N/A | N/A |
| Beginning Cash Position | 278,820 | 129,630 | 84,685 | 128,797 | 142,998 |
| End Cash Position | 683,287 | 278,820 | 129,630 | 84,685 | 128,797 |
| Net Cash Flow | $404,467 | $149,190 | $44,945 | $-44,112 | $-14,201 |
| Free Cash Flow | |||||
| Operating Cash Flow | 345,627 | 602,906 | 174,149 | -112,105 | 21,125 |
| Capital Expenditure | -30,905 | -13,608 | -34,764 | -7,107 | -7,692 |
| Free Cash Flow | 314,722 | 589,298 | 139,385 | -119,212 | 13,433 |